Edition:
United Kingdom

People: Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

2.30USD
16 Nov 2018
Change (% chg)

$0.24 (+11.65%)
Prev Close
$2.06
Open
$2.06
Day's High
$2.34
Day's Low
$2.06
Volume
47,848
Avg. Vol
32,038
52-wk High
$4.55
52-wk Low
$1.68

Chow, Gregory 

Mr. Gregory K. Chow is Chief Financial Officer, Senior Vice President of Aptose Biosciences Inc. Previously, Mr. Chow served as Managing Director, Director of Private Placements at Wedbush Securities, where he led the private placement capital activities within the Life Sciences Investment Banking Group. Prior to joining Wedbush, he was a Director in the Private Placements / Equity Capital Markets Group at RBC Capital Markets, where he led life science private capital activities. Previously, he led the Private Capital Group at Wells Fargo Securities and was a Senior Auditor at BDO Seidman, LLP in their Century City, CA office. Mr. Chow is a Certified Public Accountant (inactive) in the State of California. Mr. Chow received his MBA in Finance from The Wharton School at the University of Pennsylvania, and his BA in Business Economics with an emphasis in Accounting from the University of California, Santa Barbara.

Basic Compensation

Total Annual Compensation, CAD 664,443
Restricted Stock Award, CAD --
Long-Term Incentive Plans, CAD --
All Other, CAD --
Fiscal Year Total, CAD 664,443

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --